Russia, China, Mideast Funds to Buy Stake in Obolenskoe

Bloomberg, 26.04.2019

(Bloomberg) -- The consortium of Russian Direct Investment Fund, Russia-China Investment Fund and unidentified Middle Eastern funds agrees to join the deal to acquire stake in Russian pharmaceutical producer Obolenskoe, RDIF says in statement.

Investors plan to merge Obolenskoe with AFK Sistema’s Binnopharm to create largest pharmaceutical producer in Russia

In Dec. 2018, Sistema, VTB Bank and Obolenskoe managers bought Obolenskoe for 15.5b rubles, RDIF says